Investors may be tracking sell-side analyst opinions on shares of Amgen Inc. (NASDAQ:AMGN). According to analysts polled by Zacks Research, the current consensus target price is $202.25. Analysts and financial institutions may use different methods to value a particular stock. Because of the use of alternate methods, individual price targets may be widely varied. Viewing the consensus target price can help provide a general sense of where the sell-side sees the stock heading in the future. Investors can take a look at the target projections and decide for themselves if they agree with the Street. Investors tend to take a closer look at shares when analysts provide update to price targets.
Trying to project the day to day short-term movements of the stock market may be all but impossible. Stocks have the tendency to make sudden moves on even the slightest bit of news or for apparently no reason at all. The daily trader may be looking to capitalize on swings or momentum, but the long-term investor may be searching for stability and consistency over a sustained period of time. During trading sessions, stock movements can seem like a popularity contest from time to time. Even after careful study, there may be no logical reason for a particular stock move. Riding out the waves of uncertainty may not be easy, but having a full-proof plan for when markets erode may just be the savior. Having the patience to wait out abnormal moves may help evade the mistake of letting go too soon out of panic.
Street analysts often provide stock recommendations for companies that they track. According to analysts polled by Zacks Research, the current average rating on shares of Amgen Inc. (NASDAQ:AMGN) is 2.18. This average rating includes analysts who have given Buy, Sell and Hold ratings on the name. This rating uses a numerical scale from 1 to 5. A 1 would indicate a Buy recommendation, and a score of 5 would point to a Sell recommendation. Out of all the analysts offering recommendations, 8 have rated the stock a Strong Buy or Buy.
Covering analysts are looking for Amgen Inc. (NASDAQ:AMGN) to report a current quarter EPS of 3.38 when the company issues their next earnings report. This is the consensus estimate using analysts taken into consideration by Zacks Research. This estimate includes 10 sell-side analysts. For the previous reporting period, the company posted a quarterly EPS of 3.83. Investors will be closely tracking how close the actual comes to the consensus estimate after the next report. Analysts covering the stock are usually very busy during earnings periods. Before the release, they might be revising estimates. After the earnings release, they will closely review the information and update accordingly.
Looking at some recent stock price activity for Amgen Inc. (NASDAQ:AMGN), we have spotted shares trading near the $200.58 level. Looking at some popular historical levels, we note that the 52-week high is presently $202.93, and the 52-week low is currently $166.05. When the stock is trading close to the 52-week high or 52-week low, investors may pay extra attention to see if there will be a move through that level. Looking back over the last 12 weeks, the stock has moved 7.84%. Heading back to the start of the year, we can see that shares have moved 15.34%. Over the past 4 weeks, shares have seen a change of 2.11%. Over the last 5 trading sessions, the stock has moved 2.26%.
Investors may be getting ready to buy into the stock market as we cruise into the second half of the year. Filtering out the constant noise in the markets can be challenging. Sifting through all the data can be trying, especially for the novice investor. Digging down into the fundamentals may help weed out the undesirable companies. Investors will most likely be scouting out the equity market for any bargains. Although they may be harder to find these days, there still may be a hidden gem out there somewhere. As companies start to report quarterly earnings, investors will be closely following to see which ones are poised for success over the next few quarters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.